Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in sinus rhythm to halt ventricular tachycardia trial (SMASH-VT)

Procedural Predictors in SMASH-VT. Background: The Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial is the largest randomized trial in substrate-based ablation. We performed a retrospective analysis of patients randomized to prophylactic ablation of ven...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiovascular Electrophysiology Vol. 21; no. 7; pp. 799 - 804
Autores principales: Tung R, Josephson ME, Reddy V, Reynolds MR
Formato: clinical trial research tables/charts Journal Article
Publicado: Wiley-Blackwell Jul2010
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105046017&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105046017
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10453873
        GSB
      jtl: Journal of Cardiovascular Electrophysiology
      issn: 10453873
      maglogo: Y
    pubinfo:
      dt: Jul2010
      vid: 21
      iid: 7
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        105046017
        105046017
        2010704861
        10.1111/j.1540-8167.2009.01705.x
        NLM20132389
        105046017
      ppf: 799
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in sinus rhythm to halt ventricular tachycardia trial (SMASH-VT)
      aug:
        au:
          Tung R
          Josephson ME
          Reddy V
          Reynolds MR
        affil: UCLA Medical Center, Los Angeles, California
      sug:
        subj:
          Catheter Ablation
          Defibrillators, Implantable
          Electrophysiology
          Tachycardia, Ventricular
          Treatment Outcomes
          Aged
          Chi Square Test
          Clinical Trials
          Cox Proportional Hazards Model
          Female
          Funding Source
          Human
          Kaplan-Meier Estimator
          Male
          Medical Records
          Middle Age
          Multivariate Analysis
          Random Assignment
          Retrospective Design
          United States
          Wilcoxon Rank Sum Test
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Procedural Predictors in SMASH-VT. Background: The Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial is the largest randomized trial in substrate-based ablation. We performed a retrospective analysis of patients randomized to prophylactic ablation of ventricular tachycardia to determine the predictive value of clinical and procedural variables on outcomes. Methods: In patients treated with catheter ablation, we examined predictors of ICD-therapy free survival using Cox proportional hazards models. Procedural variables tested included the scar location, number of VT morphologies (VTs) induced, tachycardia cycle length, catheter irrigation, catheter approach, procedural duration, and VT inducibility after ablation. Clinical variables including age, index arrhythmia, NYHA class, ejection fraction, prior revascularization, and baseline medication use were also analyzed. Results: Among 64 patients randomized to ablation, 61 received the assigned therapy and complete procedural data were available for 54 patients. Thirteen percent (7 of 54) experienced ICD therapies during 2-year follow-up. Patients with subsequent ICD therapies had significantly more VTs induced during the ablation procedure than those without (3.9 ± 2.1 vs 1.9 ± 1.8, P = 0.05). The hazard ratio for each additional VT induced was 1.51 (95% CI 1.07-2.13, P = 0.02). Two-year Kaplan-Meier event-free survival rates were 96% for 0-1 VTs induced, and 78% for two or more. The use of irrigated catheters was not predictive of ablation success. Conclusion: In this small retrospective analysis, the number of VTs induced during the procedure was predictive of 2-year outcomes. This likely reflects a more complex arrhythmia substrate in patients who fail ablation. (J Cardiovasc Electrophysiol, Vol. pp. 799-803, July 2010)
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N